BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6094172)

  • 1. Female hirsutism: pathophysiological considerations and therapeutic implications.
    Biffignandi P; Massucchetti C; Molinatti GM
    Endocr Rev; 1984; 5(4):498-513. PubMed ID: 6094172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology and therapy of female idiopathic hirsutism. State of the art].
    Molinatti GM; Biffignandi P
    Ann Ital Med Int; 1990; 5(1):39-47. PubMed ID: 2144992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirsutism.
    Mauvais-Jarvis P; Kuttenn F; Mowszowicz I
    Monogr Endocrinol; 1981; 19():1-116. PubMed ID: 6454061
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.
    Pugeat M; Forest MG; Nisula BC; Corniau J; De Peretti E; Tourniaire J
    Obstet Gynecol; 1982 Jan; 59(1):46-51. PubMed ID: 6804896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hirsutism.
    Chapman MG
    Br J Hosp Med; 1981 Sep; 26(3):270-3. PubMed ID: 6456786
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17 beta-estradiol.
    Jasonni VM; Bulletti C; Naldi S; Di Cosmo E; Cappuccini F; Flamigni C
    Fertil Steril; 1991 Apr; 55(4):742-5. PubMed ID: 1826278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism].
    Pugeat M; Nicolas MH; Déchaud H; Elmidani M
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1057-62. PubMed ID: 1839798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of hirsutism: experience with cyproterone acetate and spironolactone.
    Thomas AK; Slobodniuk R; Taft J; Cooper M; Montalto J; Jerums G
    Australas J Dermatol; 1985 Apr; 26(1):19-24. PubMed ID: 2933024
    [No Abstract]   [Full Text] [Related]  

  • 13. Hirsutism.
    Morris DV
    Clin Obstet Gynaecol; 1985 Sep; 12(3):649-74. PubMed ID: 3905161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen metabolism in hirsute patients treated with cyproterone acetate.
    Mowszowicz I; Wright F; Vincens M; Rigaud C; Nahoul K; Mavier P; Guillemant S; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem; 1984 Mar; 20(3):757-61. PubMed ID: 6231428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of hirsutism in females with adrenal enzyme defects of steroid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate].
    Frank-Raue K; Junga G; Raue F; Vecsei P; Ziegler R
    Klin Wochenschr; 1990 Jun; 68(12):597-601. PubMed ID: 2142968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovarian disease: current concepts of pathophysiology and therapy.
    Coney P
    Fertil Steril; 1984 Nov; 42(5):667-82. PubMed ID: 6237940
    [No Abstract]   [Full Text] [Related]  

  • 17. The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy.
    Ismail AA; Davidson DW; Souka AR; Barnes EW; Irvine WJ; Kilimnik H; Vanderbeeken Y
    J Clin Endocrinol Metab; 1974 Jul; 39(1):81-95. PubMed ID: 4835125
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of female hirsutism: current status and new findings].
    De Pedrini P; Suraci C; Costa C
    Clin Ter; 1983 Mar; 104(6):447-55. PubMed ID: 6221859
    [No Abstract]   [Full Text] [Related]  

  • 19. Ovarian and adrenal contributions to peripheral androgens in hirsute women.
    Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
    Obstet Gynecol; 1975 Aug; 46(2):169-73. PubMed ID: 125398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Available anti-androgens for treating skin hyperandrogenism].
    Pugeat M
    Rev Fr Gynecol Obstet; 1989 Jun; 84(6):505-8. PubMed ID: 2528199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.